EN
AR
EuroPCR 2022 banner

Purposeful innovation. Empowered care.

Philips at EuroPCR 2022
17-20 May,
Palais des Congrès, Paris.


To empower better heart care, Philips uniquely innovates and integrates imaging, devices, software, informatics and services.

We look forward to connecting with you online or at our booth F22.

    Join our symposium

    Clinicians operating Azurion Clarity IQ

    How to decrease operator dependence on vessel opacification during PCI? A crash course on ultra-low contrast.

    May 17 | 17:15-18:15 | Studio A

    Moderator : Nieves Gonzalo
    Anchorperson: Jean Fajadet
    Speakers: Javier Escaned, Billal Patel, Dariusz Dudek, Jeffrey Moses

    Training village


    Our solutions support interventionalists in minimizing the contrast-load for the patient and physicians, and in performing interventional procedures with clarity and confidence,  improving cardiac care experiences for staff and patients. Join our training village at EuroPCR and learn more.

    Connect with us

    Connect with us

    Request a meeting for a personalized conversation centered around your needs.

    Explore solution demos

    Explore solution demos

    Watch in-depth demonstrations on a wide range of our solutions.

    Discover our new innovations in cardiology that deliver clinical confidence and efficiency in the diagnosis and treatment in CAD and SHD.

    Product availability is subject to country regulatory clearance. Please contact your local sales representative to check availability in your country.

    IntraSight Mobile video thumbnail

    IntraSight Mobile

    IntraSight Mobile is an easy-to-use, small footprint, IVUS imaging and physiology system, designed for coronary and peripheral vascular procedures, operable directly from the sterile field.

    Ultra low contrast PCI thumbnail

    Ultra low contrast PCI

    Most cardiac patients fall under high-risk category for acute kidney injury (AKI) 1

    EchoNavigator release 4.0 thumbnail

    EchoNavigator Release 4.0

    Helps to strengthen and streamline communication and collaboration, delivers automated anatomical insights, enables simultaneous visualization of devices, soft tissue and 3D imaging, and supports an advanced fusion imaging workflow.

    Azurion R2.1 Intrasight integration video thumbnail

    Azurion R2.1

    Philips Azurion is the next generation image-guided therapy platform that allows you to easily and confidently perform procedures with a unique user experience, helping you optimise your lab performance and provide superior care.

    Hemo with IntelliVue X3 video thumbnail

    Hemo with IntelliVue X3

    Philips introduces the Interventional Hemodynamic system (Hemo system) which brings advanced hemodynamic measurements to the cath lab. Integrated with the market leading IntelliVue X3 patient monitor, this unique combination enables continuous patient monitoring throughout the cath lab.

    Continuous monitoring video thumbnail

    Continuous monitoring

    The IntelliVue X3 portable monitor stays connected to the patient for consistent physiological monitoring and timely detection of potential adverse events during every stage of their journey.

    Sign up to receive news and updates on our new innovations in cardiology that deliver clinical confidence and efficiency in the diagnosis and treatment in CAD and SHD.

    Enter our cardiology virtual space


    Explore all the latest Philips cardiology innovations including our informatics solutions which bring meaningful data together across the cardiovascular care continuum.

    Clinical and workflow solutions

    iFR co-registration

    iFR Co-registration

    IVUS guidance

    IVUS guidance

    Coronary diagnostic for complex PCI

    Coronary diagnostic for Complex PCI

    IntelliSpace Cardiovascular orchestrating your interventional workflow

    IntelliSpace Cardiovascular

    Our PR Contacts

    Public relations contact persons image

    Joost Maltha

    Joost.maltha@philips.com

    Philips Global Press Office

    Tel: +31 6 10 55 8116

    1
    Select your area of interest
    2
    Contact details

    We are always interested in engaging with you.

    Let us know how we can help.

    1
    2
    Contact details

    References:

    1 Mehran R, Aymong ED, Nikolsky E, et al. A simple risk score for prediction of contrast induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol. 2004; 44(7): 1393-1399. doi:10.1016/j.jacc.2004.06.068.

    You are about to visit a Philips global content page

    Continue

    You are about to visit the Philips USA website.

    I understand

    You are about to visit a Philips global content page

    Continue

    You are about to visit the Philips USA website.

    I understand

    Our site can best be viewed with the latest version of Microsoft Edge, Google Chrome or Firefox.